(Registrieren)

EANS-Adhoc: LifeWatch AG to announce Full Fiscal Year 2009 and Fourth Quarter 2009 Results on February 24, 2010 - Press release at 7:00 a.m. CET - Analyst and media conference held in Zurich at 11:0

Geschrieben am 05-02-2010


--------------------------------------------------------------------------------
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
distribution. The issuer is solely responsible for the content of this
announcement.
--------------------------------------------------------------------------------


annual report

05.02.2010

Neuhausen am Rheinfall / Switzerland - LifeWatch AG (SIX Swiss
Exchange: LIFE) announces its results for the full fiscal year 2009
and the fourth quarter 2009 on Wednesday, February 24, 2010 in
Zurich.

The PDF-Version of this invitation and a registration form can be
downloaded at:

http://www.newsaktuell.ch/pdf/registration_form.pdf
http://www.newsaktuell.ch/pdf/lifewatch_invite_q4_e.pdf

Press Release at 7:00 a.m. CET (1:00 a.m. EST) The results for the
full fiscal year 2009 and the fourth quarter 2009 will be issued
internationally at 7:00 a.m. CET.

Analysts´ and Media conference at 11:00 a.m. CET LifeWatch will
report in detail on the full fiscal year 2009 and the fourth quarter
2009 results at an English-speaking analysts´ and media conference
which takes place in Zurich on

Wednesday, February 24, 2010; 11:00 a.m. CET, at the Zunfthaus
zur Saffran, Limmatquai 54, 8001 Zurich/Switzerland

Please confirm your participation at the analyst/media conference by
returning the registration form by February 17, 2010.

International Live-Conference Call/Audio Webcast at 11:00 a.m. CET
For international participants a combined conference call and audio
webcast, accompanied by presentation visuals, is broadcasted online
at 11:00 a.m CET (05:00 a.m. EST) live from the conference in Zurich.
Further information regarding the audio webcast and respective
technical requirements can be found in the Investor Relations section
of the LifeWatch Website www.lifewatch.com in due time. An archived
version of the webcast will remain available for download.

The local dial-in numbers for the conference call are as follows:

+ 41 (0)91 610 56 00 (Europe)
+ 44 (0)207 107 06 11 (UK)
+1 (1)866 291 41 66 (USA - Toll-free)

All participants should dial in at least ten minutes prior to the
call. There is no PIN required to access the call.

end of ad-hoc-announcement


================================================================================
About LifeWatch AG

LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on SIX Swiss


Exchange (LIFE), Switzerland, is the leading healthcare technology
and solution company, specializing in advanced telehealth systems and
wireless remote patient monitoring services. LifeWatch services treat
high-risk and chronically ill patients, health conscious consumers
and wellness programs. LifeWatch has subsidiaries in the United
States, the Netherlands, Japan, the United Kingdom, Switzerland and
Israel. LifeWatch AG is the parent company of LifeWatch Services
Inc., a leading US-based cardiac monitoring service provider, and
manufacturer of telecardiology products. LifeWatch is also
introducing a new program for Home SleepTesting of Obstructive Sleep
Apnea (OSA) patients under the brand name NiteWatch. For additional
information, please visit www.lifewatch.com and
www.nitewatchservices.com

Sign-up for customized E-mail alerts and documentation requests is
available at

http://production.investis.com/lifewatch/alert-service/

This press release includes forward-looking statements. All
statements other than statements of historical facts contained in
this press release, including statements regarding future results of
operations and financial position, business strategy and plans and
objectives for future operations, are forward- looking statements.
The words “believe,” “may,” “will,” “estimate,” “continue,”
“anticipate,” “intend,” “expect” and similar expressions are intended
to identify forward-looking statements. LifeWatch AG has based these
forward- looking statements largely on current expectations and
projections about future events and financial trends that it believes
may affect the financial condition, results of operations, business
strategy, short term and long term business operations and
objectives, and financial needs. These forward-looking statements are
subject to a number of risks, uncertainties and assumptions. In light
of these risks, uncertainties and assumptions, the forward-looking
events and circumstances described may not occur and actual results
could differ materially and adversely from those anticipated or
implied in the forward- looking statements. All forward-looking
statements are based only on data available to LifeWatch AG at the
time of the issue of this press release. LifeWatch AG does not
undertake any obligation to update any forward-looking statements
contained in this press release as a result of new information,
future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR
PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS
PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH
AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN
INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH
AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE
OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S.
PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY
PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG
OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL
STATEMENTS OF THE ISSUER.


end of announcement euro adhoc
--------------------------------------------------------------------------------


ots Originaltext: LifeWatch AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Kobi Ben Efraim, Chief Financial Officer, LifeWatch AG

Tel +41 52 632 00 50 | Fax +41 52 632 00 51 | Email kobibe@lifewatch.com



Sensus Investor and Public Relations GmbH, Zürich:

Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch

Branche: Healthcare Providers
ISIN: CH0012815459
WKN: 1281545
Index: SPI, SPIEX
Börsen: Frankfurt / Open Market / XETRA
SIX Swiss Exchange / Hauptsegment
Berlin / free trade


Kontaktinformationen:

Leider liegen uns zu diesem Artikel keine separaten Kontaktinformationen gespeichert vor.
Am Ende der Pressemitteilung finden Sie meist die Kontaktdaten des Verfassers.

Neu! Bewerten Sie unsere Artikel in der rechten Navigationsleiste und finden
Sie außerdem den meist aufgerufenen Artikel in dieser Rubrik.

Sie suche nach weiteren Pressenachrichten?
Mehr zu diesem Thema finden Sie auf folgender Übersichtsseite. Desweiteren finden Sie dort auch Nachrichten aus anderen Genres.

http://www.bankkaufmann.com/topics.html

Weitere Informationen erhalten Sie per E-Mail unter der Adresse: info@bankkaufmann.com.

@-symbol Internet Media UG (haftungsbeschränkt)
Schulstr. 18
D-91245 Simmelsdorf

E-Mail: media(at)at-symbol.de

250396

weitere Artikel:
  • Aleris International reicht Restrukturierungsplan ein / Aleris geht mit größerer Finanzstärke und deutlich gesenkten operativen Kosten aus Chapter 11-Verfahren hervor Beachwood, Ohio, USA (ots) - Aleris International, Inc., ein weltweit führendes Unternehmen bei Aluminium-Walzprodukten und -Profilerzeugnissen sowie Aluminium-Recycling, gab heute bekannt, dass es seinen Restrukturierungsplan (Plan) sowie den zugehörigen Entwurf des sogenannten Disclosure Statements beim Insolvenzgericht (U.S. Bankruptcy Court) in Delaware eingereicht hat. Nach diesem Schritt im Insolvenzverfahren könnten Aleris und seine 100%igen US- Tochtergesellschaften, für die Aleris ebenfalls Gläubigerschutz angemeldet hatte, mehr...

  • Private Equity: Knappe Kredite erzwingen Strategiewechsel Frankfurt am Main (ots) - Sperrfrist: 08.02.2010 00:01 Bitte beachten Sie, dass diese Meldung erst nach Ablauf der Sperrfrist zur Veröffentlichung freigegeben ist. PwC Private Equity Trend Report 2010: Nachhaltigkeit spielt wachsende Rolle bei Investitionsentscheidung / Mehr Investments in Deutschland Die Private-Equity-Branche kämpft sich mit neuen Konzepten und Finanzierungsstrategien aus der Krise. Für 2010 rechnen sieben von zehn Finanzinvestoren mit einer Markterholung in Europa, wie aus dem "Private Equity Trend mehr...

  • Geschäftsjahr 2009: Energiedienst Holding mit NaturEnergie auf gutem Weg Laufenburg (ots) - - Gesamtleistung im schwierigen Marktumfeld auf 766 Mio. Euro gesteigert - EBIT und Unternehmensergebnis leicht unter Vorjahr - Stromabsatz geringer als im Vorjahr - Verwaltungsrat beantragt bei Generalversammlung eine unveränderte Dividende von CHF 1,40 Die Energiedienst Holding AG konnte sich 2009 in ihrem marktwirtschaftlichen Umfeld behaupten. Das Jahr 2009 war durch Rezessionseffekte und regulatorische Einflüsse geprägt. Trotz Wirtschaftskrise stieg die Gesamtleistung im Vergleich zum Vorjahr von 710 mehr...

  • EANS-Adhoc: Marseille-Kliniken AG / - Umsatzzuwachs um 5,6 % im 1. Halbjahr 2009/2010 auf 123,8 Mio. Euro - Ergebnis je Aktie von 0,08 Euro auf 0,25 Euro verbessert - Weitere Verbesserung der Ergeb -------------------------------------------------------------------------------- Ad-hoc-Meldung nach § 15 WpHG übermittelt durch euro adhoc mit dem Ziel einer europaweiten Verbreitung. Für den Inhalt ist der Emittent verantwortlich. -------------------------------------------------------------------------------- 6-Monatsbericht 08.02.2010 Berlin, 8. Februar 2010. Die Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) hat den operativen Umsatz im ersten Halbjahr des Geschäftsjahres 2009/2010 (01.07.2009 - 31.12.2009) um mehr...

  • EANS-Adhoc: Marseille-Kliniken AG / - Turnover growth of 5.6 % in first half of 2009/2010 totalling EUR 123.8 million - Earnings per share improve from EUR 0.08 to EUR 0.25 - Continued improvement -------------------------------------------------------------------------------- ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. -------------------------------------------------------------------------------- 6-month report 08.02.2010 Berlin, 8 February 2010. Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) increased operating turnover in the first half of the financial year mehr...

Mehr zu dem Thema Finanzen

Der meistgelesene Artikel zu dem Thema:

Century Casinos wurde in Russell 2000 Index aufgenommen

durchschnittliche Punktzahl: 0
Stimmen: 0

Bitte nehmen Sie sich einen Augenblick Zeit, diesen Artikel zu bewerten:

Exzellent
Sehr gut
gut
normal
schlecht